🔎 Trials Near Me

Hem › Bröstcancer › Nebraska

Kliniska studier för Bröstcancer i Nebraska

25 studier för Bröstcancer söker deltagare vid platser i Nebraska.

Städer i Nebraska

Officiell studietext (engelska)

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

  • Nebraska Cancer Specialists, Omaha
RekryterarFas 3
Ålder 18 till 100 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05827081

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

  • Research Site, Omaha
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT07205822

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • CHI Health Saint Francis, Grand Island
  • CHI Health Good Samaritan, Kearney
  • Alegent Health Immanuel Medical Center, Omaha
  • och 2 fler
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

  • Cancer Partners of Nebraska, Lincoln
  • Nebraska Cancer Specialists, Omaha
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT07102381

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • Cancer Partners of Nebraska ( Site 0068), Lincoln
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06966700

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  • Oncology Hematology West, Pc Dba Nebraska Cancer Specialists, Omaha
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07007559

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

  • Oncology Hematology West, PC dba Nebraska Cancer Specialist, Grand Island
  • Paradigm Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT07173751

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • Nebraska Cancer Specialists, Omaha
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT07109726

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

  • NHO Revive Research Institute LLC, Lincoln
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists - Legacy, Omaha
  • University of Nebraska Medical Center, Omaha
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT06492616

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  • Nebraska Cancer Specialists, Omaha
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT06982521

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Nebraska Medicine-Bellevue, Bellevue
  • CHI Health Saint Francis, Grand Island
  • Mary Lanning Memorial Hospital, Hastings
  • och 7 fler
RekryterarFas 3
Ålder 18 till 60 · Kvinnor · Uppdaterad 2 sep. 2026 · NCT05879926

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Nebraska Cancer Specialists, Omaha
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT06072612

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

  • Nebraska Cancer Specialists, Omaha
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 27 aug. 2026 · NCT07660055

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

  • Nebraska Cancer Specialists, Omaha
  • Nebraska Medicine - University of Nebraska Medical Center, Omaha
RekryterarFas 3
Ålder 18 till 100 · Alla kön · Uppdaterad 6 aug. 2026 · NCT05232916

E-Mindfulness Approaches for Living After Breast Cancer

  • CHI Health Good Samaritan, Kearney
RekryterarFas 3
Ålder 18 till 50 · Alla kön · Uppdaterad 4 aug. 2026 · NCT06748222

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Nebraska Cancer Specialists - Midwest Cancer Center - Legacy, Omaha
RekryterarFas 2
Ålder 8 och äldre · Alla kön · Uppdaterad 27 juli 2026 · NCT05503797

Integrated Cancer Repository for Cancer Research

  • Mary Lanning Healthcare, Morrison Cancer Center, Hastings
  • Faith Regional Health Services, Carson Cancer Center, Norfolk
  • Great Plains Regional Medical Center, North Platte
  • och 3 fler
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 19 till 110 · Alla kön · Uppdaterad 29 juni 2026 · NCT02012699

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

  • Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
  • XCancer Omaha / Urology Cancer Center, Omaha
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 11 juni 2026 · NCT05283330

ERAS Protocols in Breast Conserving Surgery

  • University of Nebraska Medical Center, Omaha
Rekryterar
Ålder 19 och äldre · Alla kön · Uppdaterad 19 maj 2026 · NCT06938581

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  • Nebraska Medicine-Bellevue, Bellevue
  • CHI Health Good Samaritan, Kearney
  • Cancer Partners of Nebraska, Lincoln
  • och 2 fler
RekryterarFas 3
Ålder 50 till 70 · Alla kön · Uppdaterad 23 apr. 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • CHI Health Good Samaritan, Kearney
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 17 mars 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Omaha
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer

  • Biotheryx Investigative Site, Omaha
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 6 juni 2025 · NCT06515470

CtDNA Based MRD Testing for NAC Monitoring in TNBC

  • Nebraska Methodist, Omaha
RekryterarObservationsstudie
Ålder 18 och äldre · Kvinnor · Uppdaterad 7 jan. 2025 · NCT06230185

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.